Jakafi

From WikiMD.org
Jump to navigation Jump to search
Jakafi
TermJakafi
Short definitionJakafi (JA-kah-fy) A drug used to treat adults with certain types of primary myelofibrosis (MF), post-polycythemia vera MF, post-essential thrombocythemia MF, or polycythemia vera, and adults and Children 12 years and older with acute or chronic graft-versus-host disease. It is also being studied in the treatment of some types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Jakafi - (pronounced) (JA-kah-fy) A drug used to treat adults with certain types of primary myelofibrosis (MF), post-polycythemia vera MF, post-essential thrombocythemia MF, or polycythemia vera, and adults and Children 12 years and older with acute or chronic graft-versus-host disease. It is also being studied in the treatment of some types of cancer. Jakafi blocks a protein called JAK, which can help prevent abnormal blood cells or cancer cells from growing. It can also decrease the body's immune response. Jakafi is a type of tyrosine kinase inhibitor. Also called ruxolitinib phosphate

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski